50 results
Categories
Human Remove Human filter
Corporate Remove Corporate filter
Veterinary Remove Veterinary filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
PRAC, Last updated: 13/03/2020 -
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
Press release: Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors
PRAC, Last updated: 15/05/2020 -
List item
News: PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids
PRAC, Last updated: 04/09/2020 -
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
PRAC, Last updated: 09/07/2021 -
List item
News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect
PRAC, Last updated: 22/07/2021 -
List item
News: COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis
PRAC, Last updated: 11/06/2021 -
List item
News: COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
PRAC, Last updated: 14/04/2021 -
List item
News: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 20/04/2021 -
List item
News: EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
PRAC, Last updated: 09/07/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
PRAC, Last updated: 10/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update
PRAC, Last updated: 11/03/2021 -
List item
News: Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
PRAC, Last updated: 16/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
PRAC, Last updated: 25/03/2021 -
List item
News: AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
PRAC, Last updated: 31/03/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 07/04/2021 -
List item
News: Vaxzevria: EMA advises against use in people with history of capillary leak syndrome
PRAC, Last updated: 11/06/2021 -
List item
News: EMA recommends withdrawal of marketing authorisation for amfepramone medicines
PRAC, Last updated: 10/06/2022 -
List item
News: PRAC starts review of topiramate use in pregnancy and women of childbearing potential
PRAC, Last updated: 02/09/2022 -
List item
News: Review of pholcodine medicines started
PRAC, Last updated: 02/09/2022 -
List item
News: New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
PRAC, Last updated: 30/09/2022 -
List item
News: EMA confirms recommendation to withdraw marketing authorisations for amfepramone medicines
PRAC, Last updated: 28/10/2022 -
List item
News: EMA recommends withdrawal of pholcodine medicines from EU market
PRAC, Last updated: 02/12/2022